津巴布韦高危人群中的耐多药结核病。
Drug-resistant tuberculosis in high-risk groups, Zimbabwe.
出版信息
Emerg Infect Dis. 2014 Jan;20(1):135-7. doi: 10.3201/eid2001.130732.
Abstract
To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.
摘要
为了估计 2012 年津巴布韦哈拉雷地区耐多药结核病（MDR-TB）的流行情况，我们对先前经治的涂阳肺结核患者的痰标本进行了分枝杆菌培养和药敏试验。在 84 份标本中，有 20 份（24%）符合 MDR-TB 标准。需要开展全国性耐药调查以确定津巴布韦的 MDR-TB 流行率。
相似文献
1
Drug-resistant tuberculosis in high-risk groups, Zimbabwe.津巴布韦高危人群中的耐多药结核病。
Emerg Infect Dis. 2014 Jan;20(1):135-7. doi: 10.3201/eid2001.130732.
2
Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.津巴布韦耐药结核病的流行情况：基于卫生机构的横断面调查。
Int J Infect Dis. 2019 Oct;87:119-125. doi: 10.1016/j.ijid.2019.07.021. Epub 2019 Jul 27.
3
Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.印度北部 HIV 血清阳性和血清阴性肺结核患者分离的结核分枝杆菌多药耐药情况。
BMC Infect Dis. 2013 Mar 15;13:137. doi: 10.1186/1471-2334-13-137.
4
Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.尼日利亚奥孙州胸科诊所就诊的结核病患者中耐多药结核病的流行情况。
Curr Pharm Biotechnol. 2020;21(10):939-947. doi: 10.2174/1389201021666200226100242.
5
Prevalence of Multi-Drug Resistant in Khyber Pakhtunkhwa - A High Tuberculosis Endemic Area of Pakistan.在巴基斯坦高结核病流行地区开伯尔-普赫图赫瓦省，耐多药的流行情况。
Pol J Microbiol. 2020;69(2):1-5. doi: 10.33073/pjm-2020-005.
6
Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.津巴布韦哈拉雷市耐药结核病诊断的显微镜观察药物敏感性检测。
PLoS One. 2013;8(2):e55872. doi: 10.1371/journal.pone.0055872. Epub 2013 Feb 11.
7
Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴涂片阴性疑似肺结核患者中结核病、耐多药结核病及相关危险因素的流行情况。
BMC Infect Dis. 2019 Jul 19;19(1):641. doi: 10.1186/s12879-019-4241-7.
8
Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi.马拉维利隆圭肺结核住院患者的耐药情况及治疗结果
Malawi Med J. 2012 Jun;24(2):21-4.
9
Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.安哥拉农村地区结核分枝杆菌复合群耐药情况。
Emerg Infect Dis. 2018 Mar;24(3):569-572. doi: 10.3201/eid2403.171562.
10
Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.中国耐多药结核分枝杆菌的横断面全基因组测序和流行病学研究。
Clin Infect Dis. 2019 Jul 18;69(3):405-413. doi: 10.1093/cid/ciy883.
引用本文的文献
1
Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis.耐多药结核病的危险因素：一项全球性系统评价和荟萃分析。
PLoS One. 2022 Jun 16;17(6):e0270003. doi: 10.1371/journal.pone.0270003. eCollection 2022.
2
Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study.津巴布韦哈拉雷利福平耐药结核病患者的卫生保健寻求模式：一项前瞻性队列研究。
PLoS One. 2021 Jul 16;16(7):e0254204. doi: 10.1371/journal.pone.0254204. eCollection 2021.
3
Spatial patterns of pulmonary tuberculosis (TB) cases in Zimbabwe from 2015 to 2018.津巴布韦 2015 年至 2018 年肺结核（TB）病例的空间分布模式。
PLoS One. 2021 Apr 8;16(4):e0249523. doi: 10.1371/journal.pone.0249523. eCollection 2021.
4
A Comparative Study of Chest Computed Tomography Findings: 1030 Cases of Drug-Sensitive Tuberculosis versus 516 Cases of Drug-Resistant Tuberculosis.胸部计算机断层扫描结果的对比研究：1030例药物敏感型肺结核与516例耐药型肺结核
Infect Drug Resist. 2021 Mar 18;14:1115-1128. doi: 10.2147/IDR.S300754. eCollection 2021.
5
HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis.HIV 感染与耐多药结核病：系统评价和荟萃分析。
BMC Infect Dis. 2021 Jan 11;21(1):51. doi: 10.1186/s12879-020-05749-2.
6
Low pectoralis muscle index, cavitary nodule or mass and segmental to lobar consolidation as predictors of primary multidrug-resistant tuberculosis: A comparison with primary drug sensitive tuberculosis.低胸肌指数、空洞性结节或肿块以及节段性至肺叶性实变作为原发性耐多药结核病的预测因子：与原发性药敏结核病的比较。
PLoS One. 2020 Oct 5;15(10):e0239431. doi: 10.1371/journal.pone.0239431. eCollection 2020.
7
Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012-2017: a secondary dataset analysis.2012-2017 年津巴布韦哈拉雷地区细菌病原体的抗药性趋势：二次数据集分析。
BMC Infect Dis. 2019 Aug 27;19(1):746. doi: 10.1186/s12879-019-4295-6.
8
Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.津巴布韦耐药结核病的流行情况：基于卫生机构的横断面调查。
Int J Infect Dis. 2019 Oct;87:119-125. doi: 10.1016/j.ijid.2019.07.021. Epub 2019 Jul 27.
9
Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study.津巴布韦成人复发性肺结核幸存者的慢性肺部疾病：一项队列研究。
Int J Tuberc Lung Dis. 2019 Feb 1;23(2):203-211. doi: 10.5588/ijtld.18.0313.
10
Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.与埃塞俄比亚一家三级武装部队转诊和教学医院的耐多药结核病（MDR-TB）相关的风险因素。
BMC Infect Dis. 2018 May 31;18(1):249. doi: 10.1186/s12879-018-3167-9.
本文引用的文献
1
Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.南非约翰内斯堡耐多药结核病的流行传播。
J Clin Microbiol. 2013 Jun;51(6):1818-25. doi: 10.1128/JCM.00200-13. Epub 2013 Apr 3.
2
Control of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural Malawi.在马拉维农村一个得到充分支持的结核病规划背景下，（多种）耐药性和结核病发病率 23 年来的控制情况。
PLoS One. 2013;8(3):e58192. doi: 10.1371/journal.pone.0058192. Epub 2013 Mar 6.
3
Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.津巴布韦哈拉雷市耐药结核病诊断的显微镜观察药物敏感性检测。
PLoS One. 2013;8(2):e55872. doi: 10.1371/journal.pone.0055872. Epub 2013 Feb 11.
4
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.全球抗结核药物耐药性监测：2007-2010 年更新分析。
Bull World Health Organ. 2012 Feb 1;90(2):111-119D. doi: 10.2471/BLT.11.092585. Epub 2011 Nov 7.
5
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.2009-2010 年，斯威士兰耐多药结核病高度流行。
Emerg Infect Dis. 2012 Jan;18(1):29-37. doi: 10.3201/eid1801.110850.
6
Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey.莫桑比克的耐多药结核病正在增加吗？一项全国耐药性调查的结果。
Eur Respir J. 2011 Jul;38(1):222-4. doi: 10.1183/09031936.00182010.
7
Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial.比较两种基于社区的主动病例发现策略在津巴布韦哈拉雷针对症状性涂片阳性肺结核和传染性肺结核控制方面的效果（DETECTB）：一项整群随机试验。
Lancet. 2010 Oct 9;376(9748):1244-53. doi: 10.1016/S0140-6736(10)61425-0.
8
Challenges in estimating the total burden of drug-resistant tuberculosis.估算耐多药结核病总负担面临的挑战。
Am J Respir Crit Care Med. 2008 Jun 15;177(12):1302-6. doi: 10.1164/rccm.200801-175PP. Epub 2008 Mar 27.
9
Zimbabwe meltdown fuelling MDRTB?
S Afr Med J. 2008 Jan;98(1):15-6.
Zotero 插件